Impact of Adapted Mirror Therapy on Individuals With Hemiparesis of the Upper Limb Following a Stroke
1 other identifier
interventional
116
1 country
1
Brief Summary
Patients with upper limb hemiplegia after stroke, who were admitted in the Department of Rehabilitation Medicine, were enrolled. The study lasted 30 days for each participant. The patients enrolled were randomly divided into the experimental group and the control group, all under routine rehabilitation therapy. Additionally, the patients in the experimental group were given modified mirror therapy. On day 1 and day 30, patients' Upper Limb function were compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 8, 2024
CompletedJune 10, 2024
June 1, 2024
12 months
March 4, 2024
June 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Fugl-Meyer Assessment-Upper Extremity
The Fugl-Meyer Assessment-Upper Extremity was used to evaluate the patient's upper limb function and motor control. It included the assessment of movements in the shoulder, elbow joint, wrist, and fingers. During the assessment, the assessor observed and recorded the patient's abilities and limitations in specific actions. Based on the patient's performance in each sub-item, the assessor assigned a score using a 0-2 scale, a score of 0 indicating inability to perform, 1 indicating partial ability, and 2 indicating full ability. Finally, the scores for each sub-item were summed up to obtain an overall upper limb function score of 0-66, with scores positively correlated with the upper limb function.
day 1 and day 30
Secondary Outcomes (4)
coordinated contraction rate-Surface electromyography
day 1 and day 30
Visual Analog Scale
day 1 and day 30
Anxiety
day 1 and day 30
Depression
day 1 and day 30
Study Arms (2)
modified mirror therapy+routine rehabilitation therapy
EXPERIMENTALThe study lasted 30 days for each participant. The patients enrolled were randomly divided into the experimental group and the control group, all under routine rehabilitation therapy. Additionally, the patients in the experimental group were given modified mirror therapy.
routine rehabilitation therapy
ACTIVE COMPARATORThe study lasted 30 days for each participant. The patients enrolled were randomly divided into the experimental group and the control group, all under routine rehabilitation therapy.
Interventions
The Participants with stable vital signs were scheduled for specialized rehabilitation training upon enrollment, and targeted rehabilitation programs were selected based on the patient's specific limb function impairment, conducted by experienced rehabilitation therapists.
The patients were instructed to watch the recorded video and imitate the movements of their affected limbs. After the video ended, only the instructions and synchronized music were played. The patient was required to sit in front of a mirror table, with the mirror placed between both arms and facing the healthy side. The patient was required to recall the video based on the verbal instructions while using the healthy side to perform movement training. They were also asked to observe the reflected motion of the healthy limb in the mirror, simultaneously imagining the affected limb moving in sync (the patient focused on the front of the mirror, avoiding direct eye contact with the healthy hand, to create the sensation that it was the affected hand performing the movements).
Eligibility Criteria
You may qualify if:
- Meeting the diagnostic criteria of stroke.
- The first-onset stroke.
- Presenting with unilateral upper limb dysfunction, within Brunnstrom stage Ⅱ to Ⅳ on the affected side, and Ash-worth score ≤2.
- No obvious cognitive impairment, with Mini-Mental State Examination (MMSE) score \>21 points.
- National Institutes of Health Stroke Scale (NIHSS) score \>4 points.
- Stable vital signs, no severe diseases such as cancer, liver or kidney disorders.
- Aged 35-70 years.
- Courses of diseases 2-6 weeks.
You may not qualify if:
- Presence of aphasia, apraxia, or hemispatial neglect.
- Presence of hearing, vision, or comprehension impairments that hinder diagnosis and treatment.
- Complicate with traumas, fractures, or other progressive neuro-muscular system diseases.
- Severe spasticity in the upper limbs.
- Severe bone, joint, or muscle deformities or lesions.
- History of mental illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Affiated Hos.
Huabei, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nieto Luis, Master
Site Coordinator of United Medical Group
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Director
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 8, 2024
Study Start
August 1, 2022
Primary Completion
July 12, 2023
Study Completion
August 31, 2023
Last Updated
June 10, 2024
Record last verified: 2024-06